U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07782294) titled 'AI-Assisted Novel rbcDNA Detection for Early Gastric Cancer Diagnosis' on July 29.
Brief Summary: The goal of this clinical trial is to prospectively validate the diagnostic performance of an rbcDNA-based assay for gastric cancer detection in individuals undergoing upper gastrointestinal endoscopy. The study aims to evaluate the diagnostic accuracy of rbcDNA in distinguishing newly diagnosed, treatment-naive gastric cancer from non-cancerous gastric conditions, using endoscopic and histopathological findings as the reference standard. The study will also compare the diagnostic performance of the rbcDNA-based approach with currently ...